Literature DB >> 21256538

Shock wave lithotripsy associated with greater prevalence of hypertension.

Philip V Barbosa1, Antoine A Makhlouf, Daniel Thorner, Roland Ugarte, Manoj Monga.   

Abstract

OBJECTIVES: To determine whether shock wave lithotripsy (SWL) increases the prevalence of hypertension (HTN) at intermediate follow-up.
METHODS: All patients were treated with the Medstone STS electrohydraulic lithotripter, and the data were recorded prospectively in a centralized database. The data on the development of HTN after SWL was obtained from a questionnaire mailed to the patients who had undergone SWL from November 1999 and January 2002. Controls matched for age, sex, and body mass index were obtained from the National Health and Nutrition Examination Survey, using the demographic, body measurements, medical conditions, and blood pressure data sets. Two sets of matching controls were used to compare the prevalence of HTN between our patients and the NHANES population at SWL and at the follow-up point.
RESULTS: A total of 2041 patients responded to the questionnaire, with a median follow-up of 6 years. No statistically significant difference was found in the HTN prevalence between the patients and matched controls at SWL (26.7% vs 28.0%). At the follow-up point, the prevalence of HTN was greater in our patients (37.8%) than in the controls (32.5%, P=.0009). Of our patients, 15% have developed de novo HTN compared with the predicted rate of 6.25% from the matched controls. Male gender, age, and a greater body mass index were associated with the development of HTN, but none of the SWL parameters (number of shocks, bilateral vs unilateral, and multiple SWL sessions) were significantly associated with HTN.
CONCLUSIONS: The results of our study have indicated a small, but significant, increase in the risk of developing HTN after SWL using a third-generation electrohydraulic lithotripter at intermediate follow-up.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256538     DOI: 10.1016/j.urology.2010.11.006

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.

Authors:  Wonngarm Kittanamongkolchai; Kristin C Mara; Ramila A Mehta; Lisa E Vaughan; Aleksandar Denic; John J Knoedler; Felicity T Enders; John C Lieske; Andrew D Rule
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-01       Impact factor: 8.237

Review 2.  A systematic review and meta-analysis of new onset hypertension after extracorporeal shock wave lithotripsy.

Authors:  Cui Yu; Liu Longfei; Wang Long; Zeng Feng; Niu Jiping; Li Mao; Qi Lin; Chen Hequn
Journal:  Int Urol Nephrol       Date:  2013-10-27       Impact factor: 2.370

Review 3.  How to maximize the efficacy of shockwave lithotripsy.

Authors:  Neophytos Petrides; Safiyah Ismail; Faqar Anjum; Seshadri Sriprasad
Journal:  Turk J Urol       Date:  2020-10-30

4.  Evaluation of long-term side effects after shock-wave lithotripsy for renal calculi using a third generation electromagnetic lithotripter.

Authors:  Giacomo Maria Pirola; Salvatore Micali; Maria Chiara Sighinolfi; Eugenio Martorana; Angelo Territo; Stefano Puliatti; Giampaolo Bianchi
Journal:  Urolithiasis       Date:  2016-03-11       Impact factor: 3.436

5.  Effect of renal shock wave lithotripsy on the development of metabolic syndrome in a juvenile swine model: a pilot study.

Authors:  Rajash K Handa; Ziyue Liu; Bret A Connors; Mouhamad Alloosh; David P Basile; Johnathan D Tune; Michael Sturek; Andrew P Evan; James E Lingeman
Journal:  J Urol       Date:  2014-09-22       Impact factor: 7.450

6.  Induction of oxidative stress in kidney.

Authors:  Emin Ozbek
Journal:  Int J Nephrol       Date:  2012-04-17

7.  Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy.

Authors:  Michelle R Denburg; Thomas O Jemielita; Gregory E Tasian; Kevin Haynes; Phillip Mucksavage; Justine Shults; Lawrence Copelovitch
Journal:  Kidney Int       Date:  2016-01-04       Impact factor: 10.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.